DE FRANCESCHI, Lucia
 Distribuzione geografica
Continente #
EU - Europa 12.672
NA - Nord America 12.303
AS - Asia 8.967
SA - Sud America 1.241
AF - Africa 272
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 8
Totale 35.491
Nazione #
US - Stati Uniti d'America 12.072
RU - Federazione Russa 4.247
GB - Regno Unito 3.965
SG - Singapore 3.620
CN - Cina 2.481
IT - Italia 1.008
BR - Brasile 986
VN - Vietnam 960
HK - Hong Kong 779
SE - Svezia 663
FR - Francia 629
DE - Germania 600
IE - Irlanda 497
FI - Finlandia 486
KR - Corea 263
UA - Ucraina 179
ID - Indonesia 152
IN - India 136
CA - Canada 114
AR - Argentina 101
JP - Giappone 94
BD - Bangladesh 91
TR - Turchia 84
MX - Messico 75
NL - Olanda 74
NG - Nigeria 64
AT - Austria 63
PL - Polonia 53
PK - Pakistan 47
IQ - Iraq 43
BE - Belgio 40
ES - Italia 39
ZA - Sudafrica 39
EC - Ecuador 37
EG - Egitto 32
CO - Colombia 28
MA - Marocco 24
AU - Australia 23
VE - Venezuela 23
TG - Togo 22
PY - Paraguay 21
BJ - Benin 18
CL - Cile 18
DZ - Algeria 18
LT - Lituania 18
IR - Iran 17
UZ - Uzbekistan 17
MY - Malesia 16
OM - Oman 16
PH - Filippine 16
GR - Grecia 15
PE - Perù 15
CZ - Repubblica Ceca 13
JO - Giordania 13
NP - Nepal 13
SA - Arabia Saudita 13
TW - Taiwan 13
RO - Romania 12
KZ - Kazakistan 11
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
CH - Svizzera 9
GH - Ghana 8
HU - Ungheria 8
JM - Giamaica 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
LK - Sri Lanka 7
TH - Thailandia 7
TN - Tunisia 7
LB - Libano 6
PA - Panama 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CR - Costa Rica 5
ET - Etiopia 5
LV - Lettonia 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
GM - Gambi 4
HR - Croazia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
EE - Estonia 3
HN - Honduras 3
KH - Cambogia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AG - Antigua e Barbuda 2
Totale 35.441
Città #
Southend 3.580
Singapore 1.957
Ashburn 1.387
Moscow 1.379
Jacksonville 1.249
Chandler 1.152
San Jose 1.150
Dallas 893
Hong Kong 766
Woodbridge 664
Dublin 494
Verona 480
Ann Arbor 468
The Dalles 374
Houston 367
Beijing 350
Council Bluffs 303
New York 269
Ho Chi Minh City 250
Wilmington 244
Lawrence 215
Princeton 214
Jinan 191
Los Angeles 187
Dong Ket 179
Nanjing 178
Hanoi 155
Shenyang 145
Jakarta 118
Buffalo 110
Hebei 109
Sindelfingen 108
Helsinki 104
São Paulo 99
Boardman 91
Munich 90
Tokyo 86
Santa Clara 84
Tianjin 83
Redondo Beach 77
Ningbo 74
Nanchang 70
Zhengzhou 68
Milan 66
Columbus 64
Changsha 63
Guangzhou 60
Hangzhou 58
Lancaster 56
Orem 56
Seattle 56
London 55
Abuja 53
Haikou 53
Nuremberg 50
Turku 49
Montreal 46
Vienna 46
Taizhou 42
Falls Church 41
Warsaw 40
Frankfurt am Main 37
Taiyuan 37
Brussels 36
Lappeenranta 36
Jiaxing 35
Rio de Janeiro 31
San Francisco 30
Atlanta 29
Haiphong 29
Phoenix 29
Brooklyn 28
Rome 28
Toronto 28
Da Nang 27
Denver 27
Chicago 26
Collegeville 26
Belo Horizonte 25
Fuzhou 25
Chennai 24
Amsterdam 23
Redwood City 23
Baghdad 22
Campinas 22
Falkenstein 22
Lanzhou 22
Lomé 22
Norwalk 22
Washington 22
Seoul 21
Stockholm 21
Redmond 20
Bologna 19
Mexico City 19
Birmingham 18
Boston 18
Cotonou 18
Cairo 17
Johannesburg 17
Totale 22.546
Nome #
The European Hematology Association Roadmap for European Hematology Research: a consensus document 595
EHA Roadmap for European Hematology Research. The European Hematology Association Roadmap for European Hematology Research: a consensus document. 594
Access to emergency department for acute events and identification of sickle cell disease in refugees. 428
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 293
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 275
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 262
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H 259
Mouse K-Cl cotransporte KCC1: cloning, mapping, pathological expression and functional regulation. 253
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 244
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 242
A pilot study on the efficacy of ketorolac plus tramadol infusion in management of sickle cell pain combined with erythrocytopheresis in treatment of acute severe vaso-occlusive crisis 237
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 235
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 227
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial 222
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 221
Establised and experimental treatments for sickle cell disease 220
Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy 216
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 216
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 215
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract 213
Resveratrol Induces Erythroid Maturation by Activating FOXO3 and Improves in Vivo Erythropoiesis in Normal and Beta -Thalassemic Mice 208
Climate change, air pollution, and increase of respiratory allergies: just a coincidence or something more? 207
A mutation in the iron responsive element of ferritin L-subunit gene is associated with the recently described ''hereditary hyperferritinemia-cataract syndrome''. 205
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 205
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 204
Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell disease. 203
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 202
Analisi proteomica del siero di pazienti reumatici affetti da sclerodermia e di pazienti ematologici sottoposti a trapianto con midollo che hanno sviluppato un rigetto scleroderma-like. 199
Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. 198
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 197
Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias 196
K-Cl cotransport (KCC) plays an important role in normal and b thalassemic erythropoiesis 196
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 190
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 189
New Therapeutic Options for the Treatment of Sickle Cell Disease. 189
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 188
K-Cl cotransport modulation by intracellular Mgh in erythrocytes from mic bred for low and high Mg levels 187
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 187
MODULATORS OF PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF 187
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 183
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 182
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 182
Abnormal red cell structure and function in neuroacanthocytosis 180
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 180
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 179
A novel erythroi anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis 178
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 178
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 178
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 177
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 176
Erythrocyte membrane anion exchange abnormalities in Chorea-acantocytosis:the band 3 network 173
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 172
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 170
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole 170
Might Helicobacter pylori infection be associated with distortion on taste perception? 170
Neuronal Dysfunction in iPSC-Derived Medium Spiny Neurons from Chorea-Acanthocytosis Patients Is Reversed by Src Kinase Inhibition and F-Actin Stabilization 170
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 170
Oxidative stress modulates heme levels and induces peroxiredoxin-2 in β thalassemic erythropoiesis as novel cytoprotective response 169
Abnormal red cells features associated with hereditary neurodegenerative disorders: the neuroacanthocytosis syndromes. 169
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 169
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 168
Acrylamide-agarose copolymers: improved resolution of high molecular-mass proteins in 2D electrophoresis 167
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 166
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 166
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 166
The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia 165
Use of divalent cations for inhibiting erythrocyte dehydration in vivo 165
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 165
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 164
Analysis of functional and post-translational modifications in abnormal red cells from neuroacanthocytosis 163
Endothelin receptorantagonism prevents vaso-occlusion induced hemodynamic changes, reduces renal and lung damage and abrogates hypoxia-induced mortality in experimental sickle cell disease 162
Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins 161
Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up 160
Sickle cell disease and hyperreactive malarial splenomegaly (HMS) in young immigrants from Africa. 159
Can 5-methylentetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients? 158
Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension 153
Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: A mutation in the iron-responsive element of ferritin L-subunit gene 152
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 152
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model 151
Membrane oxidative damage causes hemolitic anemia during ribavirin therapy for chronic hepatitis C 148
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury. 148
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 148
PTPε has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells 147
Functional and proteomic analysis of red cells from chorea-acanthocytosis patients 146
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 146
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 145
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis 145
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 145
Dietary ω-3 fatty acid supplementation improves murine sickle cell bone disease and reprograms adipogenesis 145
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 144
Access to emergency departments for acute events and identification of sickle cell disease in refugees 144
Red blood cell cation transport in uremic anemia:evidence for an increase K/CL cotransport activity 143
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 143
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 143
Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment 140
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 140
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 139
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 139
Role of membrane oxidative damage in the pathogenesis of hemolitic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection 139
Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment. 139
Totale 19.158
Categoria #
all - tutte 112.551
article - articoli 96.724
book - libri 0
conference - conferenze 13.124
curatela - curatele 0
other - altro 0
patent - brevetti 1.206
selected - selezionate 0
volume - volumi 1.497
Totale 225.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 0 0 345
2021/20221.696 121 403 73 133 86 64 43 93 91 46 129 414
2022/20233.607 258 332 370 591 336 826 39 213 371 108 108 55
2023/20241.970 88 167 135 217 234 263 83 130 20 64 393 176
2024/20255.154 328 296 157 912 269 203 248 259 795 314 383 990
2025/202614.032 1.023 709 1.013 2.249 3.474 946 1.410 815 1.011 767 286 329
Totale 35.781